TIMOLIDE (Timolol Maleate-Hydrochlorothiazide) is for the treatment of hypertension. It combines the antihypertensive activity of two agents: a non-selective beta-adrenergic receptor blocking agent (timolol maleate) and a diuretic (hydrochlorothiazide).
TIMOLIDE is indicated for the treatment of hypertension.
This fixed combination drug is not indicated for initial therapy of hypertension. If the fixed combination represents the dose titrated to an individual patient's needs, it may be more convenient than the separate components.
Media Articles Related to Timolide (Timolol / Hydrochlorothiazide)
CPAP Reduces Blood Pressure in Resistant Hypertension
Source: theheart.org | Medscape Cardiology Headlines [2013.12.10]
Treating individuals with sleep apnea and resistant hypertension for 12 weeks resulted in significant improvements in 24-hour mean and diastolic blood pressures, but no change in 24-hour systolic blood pressure.
Management and Monitoring of Hypertension in CKD
Source: Medscape Nephrology Headlines [2013.12.10]
What issues and challenges do clinicians face in managing and monitoring hypertension in their CKD patients? This new study describes.
Current Opinion in Nephrology and Hypertension
Use of CPAP for sleep apnea reduces blood pressure for patients with difficult to treat hypertension
Source: Hypertension News From Medical News Today [2013.12.10]
Among patients with obstructive sleep apnea and hypertension that requires 3 or more medications to control, continuous positive airway pressure (CPAP) treatment for 12 weeks resulted in a decrease in 24-hour average and diastolic blood pressure and an improvement in the nocturnal blood pressure pattern, compared to patients who did not receive CPAP, according to a study appearing in the December...
Source: MedicineNet Chronic Obstructive Pulmonary Disease (COPD) Specialty [2013.11.25]
Title: Pulmonary Hypertension
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 11/25/2013 12:00:00 AM
Increased risk of alcohol-related hypertension in individuals who flush after drinking
Source: Hypertension News From Medical News Today [2013.11.21]
Excessive drinking is a known risk factor for hypertension. Drinking that results in facial flushing indicates high sensitivity or even intolerance to alcohol. A study of the relationship between drinking and these two conditions has found that drinking-related hypertension has a lower threshold value and higher risk in flushers than in non-flushers.
Published Studies Related to Timolide (Timolol / Hydrochlorothiazide)
The efficacy of hydrochlorothiazide, timolol and enalapril in Ethiopians with essential hypertension. [1992.07]
A double-blind trial of hydrochlorothiazide, timolol and enalapril was carried out in Ethiopians with essential hypertension at the Tikur Anbessa Hospital, Addis Abeba, between 1987 and 1990. Patients with a supine diastolic blood pleasure of 95-120 mmHg after a washout period of 2 weeks were randomized to receive hydrochlorothiazide 25 mg daily, timolol 10 mg daily or enalapril 10 mg daily...
Combined action of enalapril or timolol with hydrochlorothiazide plus amiloride in hypertension. 
59 mild to moderate hypertensives were treated for four weeks with 50 mg hydrochlorothiazide plus 5 mg of amiloride, then concomitantly with these diuretics with either enalapril (10-20 mg) or timolol (10-20 mg) in two parallel treatment groups for an additional 12 weeks in an open study... Both drug combinations can be considered efficient, well tolerated and safe in the treatment of mild to moderate hypertension.